XML 39 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Operating activities:    
Net loss $ (439,716) $ (18,944)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 485,932 438,648
Stock-based compensation 24,118 22,237
Deferred income taxes (111,000) (103,000)
Foreign currency transaction (gain)/loss (19,574) 99,779
(Increase) decrease in accounts receivable (29,220) 50,322
(Increase) decrease in inventories (97,351) (410,442)
(Increase) decrease in refundable income taxes (276,493) (13,190)
(Increase) decrease in prepaid expenses and other current assets (457,591) (719,884)
(Increase) decrease in other assets (25,676) (25,343)
Increase (decrease) in income taxes payable (199,558) 0
Increase (decrease) in accounts payable & accrued expenses and other noncurrent liabilities (15,957) 280,525
Net cash used in operating activities (1,162,086) (399,292)
Investing activities:    
Proceeds from the sale of property, plant and equipment 1,200 0
Purchase of property, plant and equipment (133,792) (130,797)
Payments received on distributor note receivable 44,927 35,352
Payment of life insurance premiums (296,415) (259,726)
Net cash used in investing activities (384,080) (355,171)
Financing activities:    
Principal payments on long-term borrowings (234,547) (392,008)
Common stock dividends paid 0 (252,380)
Purchase of stock for treasury 0 (5,364)
Net cash used in financing activities (234,547) (649,752)
Effect of exchange rate changes on cash and cash equivalents 53,236 (140,864)
Increase (decrease) in cash and cash equivalents (1,727,477) (1,545,079)
Cash and cash equivalents at beginning of period 6,656,798 5,801,042
Cash and cash equivalents at end of period $ 4,929,321 $ 4,255,963